Unknown

Dataset Information

0

Data for serum 1,5 anhydroglucitol concentration in different populations.

ABSTRACT: 1,5 anhydroglucitol (1,5-AG), is a nonmetabolized 1-deoxy form of glucose, originate mainly from the diet. 1,5-AG is a biomarker to detect and magnify hyperglycemic excursions (postprandial hyperglycemia) in diabetic patients. Concentrations of 1,5-AG has been applied as supporting biomarker to diagnosis of the major forms of diabetes (type 1, type 2, and gestational). The serum 1,5-AG reference interval is relevant to the appropriate clinical application of this biomarker. This article contains data regards to serum concentration of the biomarker primarily for healthy subjects, capture from the literature, in different populations. Correlation analysis between 1,5-AG and markers associated with diabetes and its complication were presented. The data was complementary to the study "Reference intervals for serum 1,5-anhydroglucitol in children, adolescents, adults, and pregnant women" (Welter et al., 2018). The data present in this article improve the comparisons for 1,5-AG in different conditions and methodologies.

SUBMITTER: Welter M 

PROVIDER: S-EPMC6129696 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Data for serum 1,5 anhydroglucitol concentration in different populations.

Welter Marciane M   Boritza Kátia C KC   Anghebem-Oliveira Mauren I MI   Henneberg Railson R   Hauser Aline B AB   Rego Fabiane G M FGM   Picheth Geraldo G  

Data in brief 20180901

1,5 anhydroglucitol (1,5-AG), is a nonmetabolized 1-deoxy form of glucose, originate mainly from the diet. 1,5-AG is a biomarker to detect and magnify hyperglycemic excursions (postprandial hyperglycemia) in diabetic patients. Concentrations of 1,5-AG has been applied as supporting biomarker to diagnosis of the major forms of diabetes (type 1, type 2, and gestational). The serum 1,5-AG reference interval is relevant to the appropriate clinical application of this biomarker. This article contains  ...[more]

Similar Datasets

Transcriptomics Sequencing of Raw 264.7 macrophage cells treated with 1,5-Anhydroglucitol(1,5-AG).
2023-01-03 | GSE221889 | GEO
Unknown Serum levels of 1,5-anhydroglucitol and 1,5-anhydrofructose-derived advanced glycation end products in patients undergoing hemodialysis.
| S-EPMC8369766 | biostudies-literature
Unknown Serum Levels of 1,5-Anhydroglucitol and Risk of Incident End-Stage Renal Disease.
| S-EPMC5860021 | biostudies-literature
Unknown Rare variants in SLC5A10 are associated with serum 1,5-anhydroglucitol (1,5-AG) in the Atherosclerosis Risk in Communities (ARIC) Study.
| S-EPMC6459884 | biostudies-literature
Unknown Association of 1,5-anhydroglucitol with diabetes and microvascular conditions.
| S-EPMC4215646 | biostudies-literature
Unknown Finding the clinical utility of 1,5-anhydroglucitol among primary care practitioners.
| S-EPMC7184171 | biostudies-literature
Unknown The relationship between serum 1,5-anhydroglucitol and adverse outcomes in acute coronary syndrome with and without chronic kidney disease patients.
| S-EPMC11292232 | biostudies-literature
Unknown Relationship of glycemic control markers - 1,5 anhydroglucitol, fructosamine, and glycated hemoglobin among Asian Indians with different degrees of glucose intolerance.
| S-EPMC5040052 | biostudies-literature
Unknown Serum 1,5-anhydroglucitol concentrations are a reliable index of glycemic control in type 2 diabetes with mild or moderate renal dysfunction.
| S-EPMC3263896 | biostudies-literature
Genomics Sequencing of Raw 264.7 macrophage cells treated with 1,5-Anhydroglucitol(1,5-AG).
| PRJNA916671 | ENA